These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17073811)

  • 21. Neuroprotection and thrombolysis: combination therapy in acute ischaemic stroke.
    Ly JV; Zavala JA; Donnan GA
    Expert Opin Pharmacother; 2006 Aug; 7(12):1571-81. PubMed ID: 16872260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotection in the SAINT-II aftermath.
    Hermann DM; Bassetti CL
    Ann Neurol; 2007 Dec; 62(6):677-8; author reply 678. PubMed ID: 17849454
    [No Abstract]   [Full Text] [Related]  

  • 23. Stroke management.
    Warburton E
    Clin Evid; 2003 Jun; (9):206-20. PubMed ID: 12967358
    [No Abstract]   [Full Text] [Related]  

  • 24. Cerebral microbleeds and postthrombolysis intracerebral hemorrhage risk: Updated meta-analysis.
    Cappellari M; Bovi P
    Neurology; 2016 Mar; 86(9):880-1. PubMed ID: 26928361
    [No Abstract]   [Full Text] [Related]  

  • 25. Response to letter regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials".
    Rao NM; Levine SR; Saver JL
    Stroke; 2015 Feb; 46(2):e45. PubMed ID: 25572410
    [No Abstract]   [Full Text] [Related]  

  • 26. Anesthetic management of patients with acute stroke.
    Flexman AM; Donovan AL; Gelb AW
    Anesthesiol Clin; 2012 Jun; 30(2):175-90. PubMed ID: 22901605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of new stroke therapies: outlook for neuroprotective drugs].
    Rogalewski A; Schäbitz WR
    Nervenarzt; 2008 Feb; 79(2):218-24. PubMed ID: 18214414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter by turc et Al regarding article, "defining clinically relevant cerebral hemorrhage after thrombolytic therapy for stroke: analysis of the national institute of neurological disorders and stroke tissue-type plasminogen activator trials".
    Turc G; Tisserand M; Seners P; Oppenheim C; Baron JC
    Stroke; 2015 Feb; 46(2):e43-4. PubMed ID: 25572409
    [No Abstract]   [Full Text] [Related]  

  • 29. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
    Yang Y; Li Q; Miyashita H; Howlett W; Siddiqui M; Shuaib A
    J Neurosurg; 2000 May; 92(5):841-7. PubMed ID: 10794299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New targets of neuroprotection in ischemic stroke.
    Bacigaluppi M; Hermann DM
    ScientificWorldJournal; 2008 Jul; 8():698-712. PubMed ID: 18661057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Author Response.
    Charidimou A; Werring D
    Neurology; 2016 Mar; 86(9):881. PubMed ID: 27358987
    [No Abstract]   [Full Text] [Related]  

  • 32. Novel therapies for acute ischemic stroke.
    Leker RR; Eichel R; Rafaeli G; Ben-Hur T
    Isr Med Assoc J; 2006 Nov; 8(11):788-92. PubMed ID: 17180832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of basic science research and stroke: hubris and translational stroke research.
    Lyden P
    Int J Stroke; 2011 Oct; 6(5):412-3. PubMed ID: 21951405
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic strategies for the treatment of stroke.
    Green AR; Shuaib A
    Drug Discov Today; 2006 Aug; 11(15-16):681-93. PubMed ID: 16846795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain attack: who will write the orders for thrombolytics?
    Wehrmacher WH; Iqbal O; Messmore H
    Arch Intern Med; 2000 Jan; 160(1):119-20. PubMed ID: 10632317
    [No Abstract]   [Full Text] [Related]  

  • 36. SAINT-I worked, but the neuroprotectant is not NXY-059.
    Proctor PH; Tamborello LP
    Stroke; 2007 Oct; 38(10):e109; author reply e110. PubMed ID: 17717310
    [No Abstract]   [Full Text] [Related]  

  • 37. The 2007 Feinberg lecture: a new road map for neuroprotection.
    Donnan GA
    Stroke; 2008 Jan; 39(1):242. PubMed ID: 18048866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroke Treatment Academic Industry Roundtable X: Brain Cytoprotection Therapies in the Reperfusion Era.
    Savitz SI; Baron JC; Fisher M;
    Stroke; 2019 Mar; 50(4):1026–1031. PubMed ID: 31166683
    [No Abstract]   [Full Text] [Related]  

  • 39. Understanding history, and not repeating it. Neuroprotection for acute ischemic stroke: from review to preview.
    Grupke S; Hall J; Dobbs M; Bix GJ; Fraser JF
    Clin Neurol Neurosurg; 2015 Feb; 129():1-9. PubMed ID: 25497127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice.
    Dirnagl U; Macleod MR
    Br J Pharmacol; 2009 Aug; 157(7):1154-6. PubMed ID: 19664136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.